Vincerx Pharma Inc logo

Vincerx Pharma Inc Share Price Today (NASDAQ: VINC)

Vincerx Pharma Inc share price is $0.05 & ₹4.34 as on 21 Apr 2025 IST

$0.05

▲

-0.02

(-28.57%)

Market is closed - opens 7 PM, 24 Jun 2025

Bell Icon

The stock has been delisted from the stock exchange on 22 Apr 2025

View live Vincerx Pharma Inc share price in Dollar and Rupees. Guide to invest in Vincerx Pharma Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Vincerx Pharma Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Vincerx Pharma Inc (VINC) Key Statistics

in dollars & INR

Previous Close
$0.07
Open
$0.0705
Market Capitalization
$1.4M
Today's Volume
$176.2K
Revenue TTM
$0.0
EBITDA
$-29.0M
Earnings Per Share (EPS)
$-15.85
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-431.29%

How to invest in Vincerx Pharma Inc Stock (VINC) from India?

It is very easy for Indian residents to invest directly in Vincerx Pharma Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vincerx Pharma Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vincerx Pharma Inc or VINC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vincerx Pharma Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vincerx Pharma Inc shares which would translate to 17.358 fractional shares of Vincerx Pharma Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Vincerx Pharma Inc, in just a few clicks!

Global Institutional Holdings in Vincerx Pharma Inc

  • SAGE RHINO CAPITAL LLC

    1.63%

  • Rock Springs Capital Management LP

    0.85%

  • Armistice Capital, LLC

    0.54%

  • Geode Capital Management, LLC

    0.23%

  • Rubric Capital Management LP

    0.11%

  • UBS Group AG

    0.09%

Analyst Recommendation on Vincerx Pharma Inc

Rating
Trend

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Vincerx Pharma Inc(by analysts ranked 0 to 5 stars)

About Vincerx Pharma Inc

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. The company is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with relapsed and refractory leukemia and lymphoid malignancies, as well as solid tumors and non-Hodgkin lymphoma; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat advanced or metastatic solid tumors. Its product candidates also include VIP943 in Phase 1 clinical trials for the treatment of relapsed/refractory acute myeloid leukemia, myelodysplastic syndrome, and B-cell acute lymphoblastic leukemia; and VIP924 in preclinical studies for the treatment of B-cell malignancies. Vincerx Pharma, Inc. was founded in 2019 and is based in Palo Alto, California.
Organization
Vincerx Pharma Inc
Employees
12
CEO
Dr. Raquel E. Izumi Ph.D.
Industry
Miscellaneous

Management People of Vincerx Pharma Inc

NameTitle
Dr. Ahmed M. Hamdy M.D.
Co-Founder & Chairman
Dr. Raquel E. Izumi Ph.D.
Co-Founder, Acting CEO, Secretary & Director
Mr. Tom C. Thomas J.D.
Consultant
Mr. Alexander A. Seelenberger M.B.A.
Consultant
Dr. John C. Byrd M.D.
Founder & Chairman of Scientific Advisory Board
Mr. Kevin Haas
Acting CFO, VP of Finance & Corporate Controller
Dr. Hans-Georg Lerchen Ph.D.
Chief Scientific Officer
Ms. Gabriela Jairala
VP of Investor Relations & Corporate Communications and Chief of Staff
Ms. Karen Quarford M.B.A.
Vice President of Quality Operations & Compliance
Ms. Melissa Merrick SPHR
Senior Director of People & Culture and Head of Human Resource

Important FAQs about investing in VINC Stock from India :

Can Indians buy Vincerx Pharma Inc shares?

Yes, Indians can invest in the Vincerx Pharma Inc (VINC) from India.

With INDmoney, you can buy Vincerx Pharma Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Vincerx Pharma Inc at zero transaction cost.

How can I buy Vincerx Pharma Inc shares from India?

It is very easy to buy Vincerx Pharma Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vincerx Pharma Inc (VINC) be purchased?

Yes, you can buy fractional shares of Vincerx Pharma Inc with INDmoney app.

What are the documents required to start investing in Vincerx Pharma Inc stocks?

To start investing in Vincerx Pharma Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Vincerx Pharma Inc?

Today's market capitalisation of Vincerx Pharma Inc VINC is 1.4M

Who is the Chief Executive Officer (CEO) of Vincerx Pharma Inc ?

Dr. Raquel E. Izumi Ph.D. is the current Chief Executive Officer (CEO) of Vincerx Pharma Inc.